Dr Reilly was Global Vice President, Discovery Strategy and Performance and Head of Project Evaluation at AstraZeneca from 2005 to 2011. He was also responsible for developing AZ’s research strategy, business plan and performance improvement activities. He was a member of the senior R&D Leadership team, AZ’s Board Science Committee and the R&D Committee that selected compounds for clinical development. On secondment from AZ, he worked at Advent International (Boston), from 2003 to 2005.
Dr Reilly joined the pharmaceutical industry in 1987 working first at Merck (USA) and then Zeneca (1993, UK) where he was VP, Respiratory and Inflammation Research at AZ from 1999 to 2003. He currently advises biotech/pharma, healthcare VCs, universities, medical charities, academics, and government science agencies.